Haleon (HLN) Change in Account Payables (2022 - 2025)

Haleon's (HLN) quarterly Change in Account Payables came in at $143.4 million in Q4 2025, up 12.14% on a QoQ basis from $127.8 million in Q4 2023.

Haleon (HLN) Change in Account Payables (2022 - 2025) Analysis & Trends

Haleon (HLN) has 3 years of Change in Account Payables data on file, last reported at $143.4 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Account Payables (Qtr)
1	Haleon	44.05 Bn	43.08 Bn	-	-
2	Teva Pharmaceutical Industries	43.39 Bn	39.74 Bn	2.15 Bn	-
3	Zoetis	31.86 Bn	30.18 Bn	1.05 Bn	-53.00 Mn
4	Takeda Pharmaceutical	28.78 Bn	22.99 Bn	5.10 Bn	-143.74 Mn
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn	-
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn	-21.20 Mn
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn	-
8	Elanco Animal Health	11.92 Bn	11.39 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.16 Bn	9.99 Bn	-	-
10	Alkermes	8.17 Bn	7.51 Bn	397.90 Mn	-

Download Data